Dimerix is GO, page-32

Hi TT,

Welcome onboard to DXB . Undervalued biotechs such as DXB appear to now be on the radar of brokers & I hope you make some serious money here.

We are going into a 2b trial for DMX-200, with groundbreaking results from 2A for CKD and also Diabetes related CKD, which was an unexpected and incredibly value adding result to DXB’s science & IP, and so a pivotal stage for us here. The global issue of diabetes & CKD is massive, with treatment costs in the many billions.

I personally believe our management team are excellent & very professional. They run this company like a well oiled machine.

There is a lot of information on our threads here, so maybe read back when you get the time. Really great to have some new investors here. GLTAH